Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Shares Outstanding (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Shares Outstanding for 2 consecutive years, with $51.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 158.42% to $51.4 million in Q4 2025 year-over-year; TTM through Oct 2025 was $51.4 million, a 158.42% increase, with the full-year FY2025 number at $51.3 million, up 157.91% from a year prior.
  • Shares Outstanding was $51.4 million for Q4 2025 at Kestra Medical Technologies, roughly flat from $51.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $51.4 million in Q4 2025 to a low of $105808.0 in Q1 2024.